UBC President’s Excellence Chair in Precision Oncology
The University of British Columbia (UBC) seeks to advance cancer research as a priority area with the recruitment of a President’s Excellence Chair in Precision Oncology. Precision oncology is a major multidisciplinary driver for cancer researchers at UBC, in partnership with affiliated institutions, notably BC Cancer, BC Children’s Hospital and Research Institute, BC Women’s Hospital and Research Institute, Vancouver Coastal Health, UBC Life Sciences Institute and other UBC and Faculty of Medicine Centres and Institutes.
The role of the research Chair will be to enhance UBC’s capacity in precision oncology clinical trials, and facilitate the translation of new genomic assays and other biomarkers to improve our understanding of currently incurable metastatic cancers, with an interest in the use of e.g. whole genome and single cell sequencing technologies and proteomics and/or metabolomics to study treatment resistance. The Chair will work closely within a rich environment of cancer researchers at the BC Cancer Research Centre, including Canada’s largest cancer genomics facility (Canada’s Michael Smith Genome Sciences Centre), UBC, and other affiliated institutions. The Chair will be expected to lead and coordinate a program focused on precision oncology at UBC and will combine world-class research with focused and specialized clinical activities at the BC Cancer Agency’s Vancouver Centre and/or other hospital institution as appropriate. The role is empowered by dedicated, protected time for academic activities.
The successful candidate will be a clinician scientist with established expertise in relevant areas including oncology, genomics, clinical trials, novel drug evaluation and/or development, and practical experience in working in, and implementing precision oncology platforms and clinical trials. The Chair is open to an outstanding individual who is a leader in genomics and precision oncology, and will provide medical leadership to support growing needs in precision oncology at UBC, enabling a structured approach to integrate cancer genomics in clinical trials and generate high quality knowledge that will ultimately lead to improved outcomes for cancer patients. Integration across genomics, bioinformatics, clinical oncology, biomarkers, and novel drug development are required to support many disease site programs, as well as successful growth of umbrella trials that are now being developed and led across the country by BC Cancer and other academic partners.
The successful candidate will have a MD, MD/PhD or equivalent degree with specialty training in oncology and additional training in health or basic research. The candidate should hold a valid medical practice license in relevant specialties concerning cancer. The candidate will have a successful track record of outstanding academic and clinical achievements, evidenced by high impact publications, success in attracting peer-reviewed research funding, and demonstrated results in translational research activities. The successful candidate must be eligible for registration by the College of Physicians and Surgeons of British Columbia, through the full or academic registration programs.
Salary will be commensurate with qualifications and experience. The position will include at least 70% protected academic time, with dedicated research funding to support the successful candidate for the first seven years of the program, and access to exceptional platforms in cancer biology, genomics, proteomics, conventional and molecular imaging and bioinformatics.
A letter of application, accompanied by a detailed curriculum vitae and names of four referees should be directed to:
Review of applications will begin on October 15, 2021 and will continue until the position is filled.